{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T02:02:05Z","timestamp":1789524125120,"version":"build-2803163510"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T00:00:00Z","timestamp":1789516800000},"content-version":"vor","delay-in-days":79,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["2024AFB667"],"award-info":[{"award-number":["2024AFB667"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003819","name":"Natural Science Foundation of Hubei Province","doi-asserted-by":"publisher","award":["2023AFB190"],"award-info":[{"award-number":["2023AFB190"]}],"id":[{"id":"10.13039\/501100003819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82302971"],"award-info":[{"award-number":["82302971"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81772800"],"award-info":[{"award-number":["81772800"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Oncol."],"DOI":"10.1007\/s13402-026-01240-3","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T12:56:04Z","timestamp":1782737764000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["ITGB5 promotes immune escape in hepatocellular carcinoma by regulating PD-L1 through SETDB1\/Hippo signaling pathway"],"prefix":"10.1007","volume":"49","author":[{"given":"Mengmeng","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruijiang","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"key":"1240_CR1","doi-asserted-by":"crossref","unstructured":"F. Bray, M. Laversanne, H. Sung, J. Ferlay, R.L. Siegel, I. Soerjomataram et al., Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74(3), 229\u2013263 (2024 May-Jun)","DOI":"10.3322\/caac.21834"},{"issue":"10127","key":"1240_CR2","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","volume":"391","author":"A Forner","year":"2018","unstructured":"A. Forner, M. Reig, J. Bruix, Hepatocellular carcinoma. Lancet. 391(10127), 1301\u20131314 (2018)","journal-title":"Lancet"},{"key":"1240_CR3","doi-asserted-by":"publisher","first-page":"102610","DOI":"10.1016\/j.ebiom.2019.102610","volume":"51","author":"S Xia","year":"2020","unstructured":"S. Xia, Y. Pan, Y. Liang, J. Xu, X. Cai, The microenvironmental and metabolic aspects of sorafenib resistance in hepatocellular carcinoma. EBioMedicine. 51, 102610 (2020)","journal-title":"EBioMedicine"},{"issue":"10088","key":"1240_CR4","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1016\/S0140-6736(17)31046-2","volume":"389","author":"AB El-Khoueiry","year":"2017","unstructured":"A.B. El-Khoueiry, B. Sangro, T. Yau, T.S. Crocenzi, M. Kudo, C. Hsu et al., Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1\/2 dose escalation and expansion trial. Lancet. 389(10088), 2492\u20132502 (2017)","journal-title":"Lancet"},{"issue":"26","key":"1240_CR5","doi-asserted-by":"publisher","first-page":"2960","DOI":"10.1200\/JCO.20.00808","volume":"38","author":"RS Finn","year":"2020","unstructured":"R.S. Finn, M. Ikeda, A.X. Zhu, M.W. Sung, A.D. Baron, M. Kudo et al., Phase Ib Study of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Hepatocellular Carcinoma. J. Clin. Oncol. 38(26), 2960\u20132970 (2020)","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"1240_CR6","doi-asserted-by":"publisher","first-page":"48","DOI":"10.2174\/0113892029308243240709073945","volume":"26","author":"IP Gudivada","year":"2025","unstructured":"I.P. Gudivada, K.C. Amajala, Integrative Bioinformatics Analysis for Targeting Hub Genes in Hepatocellular Carcinoma Treatment. Curr. Genomics. 26(1), 48\u201380 (2025)","journal-title":"Curr. Genomics"},{"issue":"9","key":"1240_CR7","doi-asserted-by":"publisher","first-page":"706","DOI":"10.2174\/0109298665330781240830042601","volume":"31","author":"W Ye","year":"2024","unstructured":"W. Ye, J. Wang, J. Zheng, M. Jiang, Y. Zhou, Z. Wu, Association between Higher Expression of Vav1 in Hepatocellular Carcinoma and Unfavourable Clinicopathological Features and Prognosis. Protein Pept. Lett. 31(9), 706\u2013713 (2024)","journal-title":"Protein Pept. Lett."},{"key":"1240_CR8","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1146\/annurev-biochem-013118-111829","volume":"88","author":"S Ma","year":"2019","unstructured":"S. Ma, Z. Meng, R. Chen, K.L. Guan, The Hippo Pathway: Biology and Pathophysiology. Annu. Rev. Biochem. 88, 577\u2013604 (2019)","journal-title":"Annu. Rev. Biochem."},{"key":"1240_CR9","doi-asserted-by":"publisher","first-page":"110586","DOI":"10.1016\/j.intimp.2023.110586","volume":"122","author":"C Liu","year":"2023","unstructured":"C. Liu, Y. Song, D. Li, B. Wang, Regulation of the tumor immune microenvironment by the Hippo Pathway: Implications for cancer immunotherapy. Int. Immunopharmacol. 122, 110586 (2023)","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"1240_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/gad.274027.115","volume":"30","author":"Z Meng","year":"2016","unstructured":"Z. Meng, T. Moroishi, K.L. Guan, Mechanisms of Hippo pathway regulation. Genes Dev. 30(1), 1\u201317 (2016)","journal-title":"Genes Dev."},{"issue":"4","key":"1240_CR11","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3390\/cancers10040094","volume":"10","author":"Z Taha","year":"2018","unstructured":"Z. Taha, H.J. van Janse, X. Yang, The Hippo Pathway: Immunity and Cancer. Cancers (Basel). 10(4), 94 (2018)","journal-title":"Cancers (Basel)"},{"issue":"Suppl 3","key":"1240_CR12","doi-asserted-by":"publisher","first-page":"S318","DOI":"10.21037\/jtd.2019.01.16","volume":"11","author":"SH Hong","year":"2019","unstructured":"S.H. Hong, Hippo pathway as another oncogenic mediator to promote immune evasion by PD-L1 signaling. J. Thorac. Dis. 11(Suppl 3), S318\u2013S321 (2019)","journal-title":"J. Thorac. Dis."},{"issue":"6","key":"1240_CR13","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1158\/0008-5472.CAN-17-3139","volume":"78","author":"HJ van Janse","year":"2018","unstructured":"H.J. van Janse, T. Azad, M. Ling, Y. Hao, B. Snetsinger et al., The Hippo Pathway Component TAZ Promotes Immune Evasion in Human Cancer through PD-L1. Cancer Res. 78(6), 1457\u20131470 (2018)","journal-title":"Cancer Res."},{"issue":"9","key":"1240_CR14","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1038\/s41416-023-02182-5","volume":"128","author":"J Luo","year":"2023","unstructured":"J. Luo, H. Zou, Y. Guo, T. Tong, Y. Chen, Y. Xiao et al., The oncogenic roles and clinical implications of YAP\/TAZ in breast cancer. Br. J. Cancer. 128(9), 1611\u20131624 (2023)","journal-title":"Br. J. Cancer"},{"issue":"12","key":"1240_CR15","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.3390\/biomedicines9121949","volume":"9","author":"D Matthaios","year":"2021","unstructured":"D. Matthaios, M. Tolia, D. Mauri, K. Kamposioras, M. Karamouzis, YAP\/Hippo Pathway and Cancer Immunity: It Takes Two to Tango. Biomedicines. 9(12), 1949 (2021)","journal-title":"Biomedicines"},{"issue":"5","key":"1240_CR16","doi-asserted-by":"publisher","first-page":"e1900162","DOI":"10.1002\/bies.201900162","volume":"42","author":"BJ Thompson","year":"2020","unstructured":"B.J. Thompson, YAP\/TAZ: Drivers of Tumor Growth, Metastasis, and Resistance to Therapy. Bioessays. 42(5), e1900162 (2020)","journal-title":"Bioessays"},{"issue":"4","key":"1240_CR17","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1002\/path.4482","volume":"235","author":"QY Sun","year":"2015","unstructured":"Q.Y. Sun, L.W. Ding, J.F. Xiao, W. Chien, S.L. Lim, N. Hattori et al., SETDB1 accelerates tumourigenesis by regulating the WNT signalling pathway. J. Pathol. 235(4), 559\u2013570 (2015)","journal-title":"J. Pathol."},{"key":"1240_CR18","doi-asserted-by":"publisher","first-page":"8651","DOI":"10.1038\/ncomms9651","volume":"6","author":"Q Fei","year":"2015","unstructured":"Q. Fei, K. Shang, J. Zhang, S. Chuai, D. Kong, T. Zhou et al., Histone methyltransferase SETDB1 regulates liver cancer cell growth through methylation of p53. Nat. Commun. 6, 8651 (2015)","journal-title":"Nat. Commun."},{"issue":"1","key":"1240_CR19","first-page":"30","volume":"33","author":"Y Hao","year":"2024","unstructured":"Y. Hao, X.Y. Bai, F. Huo, X.B. Chen, [Downregulation of SETDB1 suppresses epithelial mesenchymal transition and invasion and metastasis in oral cancer via SOX7 methylation]. Shanghai Kou Qiang Yi Xue. 33(1), 30\u201335 (2024)","journal-title":"Shanghai Kou Qiang Yi Xue"},{"issue":"1","key":"1240_CR20","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12943-024-01975-3","volume":"23","author":"F Luo","year":"2024","unstructured":"F. Luo, M. Zhang, B. Sun, C. Xu, Y. Yang, Y. Zhang et al., LINC00115 promotes chemoresistant breast cancer stem-like cell stemness and metastasis through SETDB1\/PLK3\/HIF1\u03b1 signaling. Mol. Cancer. 23(1), 60 (2024)","journal-title":"Mol. Cancer"},{"issue":"8","key":"1240_CR21","doi-asserted-by":"publisher","first-page":"114536","DOI":"10.1016\/j.celrep.2024.114536","volume":"43","author":"YH Chang","year":"2024","unstructured":"Y.H. Chang, K. Yamamoto, T. Fujino, T.W. Wang, E. Sugimoto, W. Zhang et al., SETDB1 suppresses NK cell-mediated immunosurveillance in acute myeloid leukemia with granulo-monocytic differentiation. Cell. Rep. 43(8), 114536 (2024)","journal-title":"Cell. Rep."},{"issue":"7866","key":"1240_CR22","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/s41586-021-03520-4","volume":"595","author":"GK Griffin","year":"2021","unstructured":"G.K. Griffin, J. Wu, A. Iracheta-Vellve, J.C. Patti, J. Hsu, T. Davis et al., Epigenetic silencing by SETDB1 suppresses tumour intrinsic immunogenicity. Nature. 595(7866), 309\u2013314 (2021)","journal-title":"Nature"},{"key":"1240_CR23","doi-asserted-by":"publisher","first-page":"4012920","DOI":"10.1155\/2022\/4012920","volume":"2022","author":"J Tian","year":"2022","unstructured":"J. Tian, W. Wang, J. Zhu, Y. Zhuang, C. Qi, Z. Cai et al., Histone Methyltransferase SETDB1 Promotes Immune Evasion in Colorectal Cancer via FOSB-Mediated Downregulation of MicroRNA-22 through BATF3\/PD-L1 Pathway. J. Immunol. Res. 2022, 4012920 (2022)","journal-title":"J. Immunol. Res."},{"issue":"24","key":"1240_CR24","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.3390\/cells13242102","volume":"13","author":"CQ Yin","year":"2024","unstructured":"C.Q. Yin, C.Q. Song, Tumor Intrinsic Immunogenicity Suppressor SETDB1 Worsens the Prognosis of Patients with Hepatocellular Carcinoma. Cells. 13(24), 2102 (2024)","journal-title":"Cells"},{"key":"1240_CR25","doi-asserted-by":"publisher","first-page":"1500263","DOI":"10.3389\/fcell.2024.1500263","volume":"12","author":"E Zhang","year":"2024","unstructured":"E. Zhang, P. He, The function of histone methyltransferase SETDB1 and its roles in liver cancer. Front. Cell. Dev. Biol. 12, 1500263 (2024)","journal-title":"Front. Cell. Dev. Biol."},{"key":"1240_CR26","doi-asserted-by":"publisher","first-page":"113745","DOI":"10.1016\/j.biopha.2022.113745","volume":"155","author":"JR Chen","year":"2022","unstructured":"J.R. Chen, J.T. Zhao, Z.Z. Xie, Integrin-mediated cancer progression as a specific target in clinical therapy. Biomed. Pharmacother. 155, 113745 (2022)","journal-title":"Biomed. Pharmacother"},{"issue":"10","key":"1240_CR27","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/nrm1490","volume":"5","author":"W Guo","year":"2004","unstructured":"W. Guo, F.G. Giancotti, Integrin signalling during tumour progression. Nat. Rev. Mol. Cell. Biol. 5(10), 816\u2013826 (2004)","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"issue":"33","key":"1240_CR28","doi-asserted-by":"publisher","first-page":"e34765","DOI":"10.1097\/MD.0000000000034765","volume":"102","author":"H Xie","year":"2023","unstructured":"H. Xie, C. Qin, X. Zhou, J. Liu, K. Yang, J. Nong et al., Prognostic value and potential molecular mechanism of ITGB superfamily members in hepatocellular carcinoma. Med. (Baltim). 102(33), e34765 (2023)","journal-title":"Med. (Baltim)."},{"issue":"9","key":"1240_CR29","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/s41568-018-0038-z","volume":"18","author":"H Hamidi","year":"2018","unstructured":"H. Hamidi, J. Ivaska, Every step of the way: integrins in cancer progression and metastasis. Nat. Rev. Cancer. 18(9), 533\u2013548 (2018)","journal-title":"Nat. Rev. Cancer"},{"issue":"25","key":"1240_CR30","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.1038\/onc.2012.320","volume":"32","author":"A Bianchi-Smiraglia","year":"2013","unstructured":"A. Bianchi-Smiraglia, S. Paesante, A.V. Bakin, Integrin \u03b25 contributes to the tumorigenic potential of breast cancer cells through the Src-FAK and MEK-ERK signaling pathways. Oncogene. 32(25), 3049\u20133058 (2013)","journal-title":"Oncogene"},{"key":"1240_CR31","doi-asserted-by":"publisher","first-page":"106789","DOI":"10.1016\/j.phrs.2023.106789","volume":"192","author":"L Gu","year":"2023","unstructured":"L. Gu, X. Jin, H. Liang, C. Yang, Y. Zhang, Upregulation of CSNK1A1 induced by ITGB5 confers to hepatocellular carcinoma resistance to sorafenib in vivo by disrupting the EPS15\/EGFR complex. Pharmacol. Res. 192, 106789 (2023)","journal-title":"Pharmacol. Res."},{"issue":"5","key":"1240_CR32","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.4110\/in.2020.20.e36","volume":"20","author":"A Bouchard","year":"2020","unstructured":"A. Bouchard, M. Witalis, J. Chang, V. Panneton, J. Li, Y. Bouklouch et al., Hippo Signal Transduction Mechanisms in T Cell Immunity. Immune Netw. 20(5), e36 (2020)","journal-title":"Immune Netw."},{"issue":"4","key":"1240_CR33","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.cell.2015.10.044","volume":"163","author":"FX Yu","year":"2015","unstructured":"F.X. Yu, B. Zhao, K.L. Guan, Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer. Cell. 163(4), 811\u2013828 (2015)","journal-title":"Cell"},{"issue":"6","key":"1240_CR34","doi-asserted-by":"publisher","first-page":"109864","DOI":"10.1016\/j.isci.2024.109864","volume":"27","author":"A Leask","year":"2024","unstructured":"A. Leask, J. Nguyen, A. Naik, P. Chitturi, B.L. Riser, The role of yes activated protein (YAP) in melanoma metastasis. iScience. 27(6), 109864 (2024)","journal-title":"iScience"},{"key":"1240_CR35","doi-asserted-by":"publisher","first-page":"109087","DOI":"10.1016\/j.abb.2021.109087","volume":"715","author":"T Liu","year":"2022","unstructured":"T. Liu, P. Xu, S. Ke, H. Dong, M. Zhan, Q. Hu et al., Histone methyltransferase SETDB1 inhibits TGF-\u03b2-induced epithelial-mesenchymal transition in pulmonary fibrosis by regulating SNAI1 expression and the ferroptosis signaling pathway. Arch. Biochem. Biophys. 715, 109087 (2022)","journal-title":"Arch. Biochem. Biophys."},{"issue":"1","key":"1240_CR36","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12943-024-02046-3","volume":"23","author":"F Liu","year":"2024","unstructured":"F. Liu, J. Chen, K. Li, H. Li, Y. Zhu, Y. Zhai et al., Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches. Mol. Cancer. 23(1), 148 (2024)","journal-title":"Mol. Cancer"},{"issue":"5","key":"1240_CR37","doi-asserted-by":"publisher","first-page":"103982","DOI":"10.1016\/j.drudis.2024.103982","volume":"29","author":"S Prashanth","year":"2024","unstructured":"S. Prashanth, R. Radha Maniswami, G. Rajajeyabalachandran, S.K. Jegatheesan, SETDB1, an H3K9-specific methyltransferase: An attractive epigenetic target to combat cancer. Drug Discov Today. 29(5), 103982 (2024)","journal-title":"Drug Discov Today"},{"key":"1240_CR38","doi-asserted-by":"publisher","first-page":"107219","DOI":"10.1016\/j.bioorg.2024.107219","volume":"145","author":"T Ma","year":"2024","unstructured":"T. Ma, F. Xu, Y. Hou, Y. Shu, Z. Zhao, Y. Zhang et al., SETDB1: Progress and prospects in cancer treatment potential and inhibitor research. Bioorg. Chem. 145, 107219 (2024)","journal-title":"Bioorg. Chem."},{"issue":"4","key":"1240_CR39","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/bjc.1972.43","volume":"26","author":"I Lauder","year":"1972","unstructured":"I. Lauder, W. Aherne, The significance of lymphocytic infiltration in neuroblastoma. Br. J. Cancer. 26(4), 321\u2013330 (1972)","journal-title":"Br. J. Cancer"},{"key":"1240_CR40","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.canlet.2021.05.037","volume":"518","author":"C Miliotis","year":"2021","unstructured":"C. Miliotis, F.J. Slack, miR-105-5p regulates PD-L1 expression and tumor immunogenicity in gastric cancer. Cancer Lett. 518, 115\u2013126 (2021)","journal-title":"Cancer Lett."},{"issue":"1","key":"1240_CR41","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12943-021-01398-4","volume":"20","author":"Z Liu","year":"2021","unstructured":"Z. Liu, T. Wang, Y. She, K. Wu, S. Gu, L. Li et al., N6-methyladenosine-modified circIGF2BP3 inhibits CD8+ T-cell responses to facilitate tumor immune evasion by promoting the deubiquitination of PD-L1 in non-small cell lung cancer. Mol. Cancer. 20(1), 105 (2021)","journal-title":"Mol. Cancer"},{"issue":"2","key":"1240_CR42","first-page":"97","volume":"16","author":"W Han","year":"2013","unstructured":"W. Han, M. Bi, [Clinical meaning of EML4-ALK fusion gene in non-small cell lung cancer]. Zhongguo Fei Ai Za Zhi. 16(2), 97\u2013101 (2013). Chinese","journal-title":"Zhongguo Fei Ai Za Zhi"},{"issue":"1","key":"1240_CR43","doi-asserted-by":"publisher","first-page":"24323","DOI":"10.1038\/s41598-025-10437-9","volume":"15","author":"S Wang","year":"2025","unstructured":"S. Wang, M. Xu, Y. Liu, X. Hou, Z. Gao, J. Sun, L. Shen, PD-L1 expression and its association with clinicopathological and computed tomography features in surgically resected non-small cell lung cancer: a retrospective cohort study. Sci. Rep. 15(1), 24323 (2025)","journal-title":"Sci. Rep."},{"issue":"1","key":"1240_CR44","doi-asserted-by":"publisher","first-page":"2","DOI":"10.2174\/0113892029273682240111052317","volume":"25","author":"R Mu","year":"2024","unstructured":"R. Mu, M. Chang, C. Feng, Y. Cui, T. Li, C. Liu, Y. Wang, X. Guo, Analysis of the Expression of PRDX6 in Patients with Hepatocellular Carcinoma and its Effect on the Phenotype of Hepatocellular Carcinoma Cells. Curr. Genomics. 25(1), 2\u201311 (2024)","journal-title":"Curr. Genomics"},{"issue":"3","key":"1240_CR45","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2174\/0115665232274223231017052707","volume":"24","author":"J Wang","year":"2024","unstructured":"J. Wang, L. Sun, Y. Liu, Y. Zhang, FIGNL1 Promotes Hepatocellular Carcinoma Formation via Remodeling ECM-receptor Interaction Pathway Mediated by HMMR. Curr. Gene Ther. 24(3), 249\u2013263 (2024)","journal-title":"Curr. Gene Ther."},{"key":"1240_CR46","doi-asserted-by":"publisher","first-page":"216953","DOI":"10.1016\/j.canlet.2024.216953","volume":"592","author":"T Lei","year":"2024","unstructured":"T. Lei, Y. Lin, X. Lai, Y. Zhang, Y. Ma, X. Wang et al., ITGB5 facilitates gastric cancer metastasis by promoting TGFBR2 endosomal recycling. Cancer Lett. 592, 216953 (2024)","journal-title":"Cancer Lett."},{"key":"1240_CR47","doi-asserted-by":"publisher","first-page":"887068","DOI":"10.3389\/fonc.2022.887068","volume":"12","author":"X Wen","year":"2022","unstructured":"X. Wen, S. Chen, X. Chen, H. Qiu, W. Wang, N. Zhang et al., ITGB5 promotes innate radiation resistance in pancreatic adenocarcinoma by promoting DNA damage repair and the MEK\/ERK signaling pathway. Front. Oncol. 12, 887068 (2022)","journal-title":"Front. Oncol."},{"issue":"2","key":"1240_CR48","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/s41556-018-0261-6","volume":"21","author":"J Guo","year":"2019","unstructured":"J. Guo, X. Dai, B. Laurent, N. Zheng, W. Gan, J. Zhang et al., AKT methylation by SETDB1 promotes AKT kinase activity and oncogenic functions. Nat. Cell. Biol. 21(2), 226\u2013237 (2019)","journal-title":"Nat. Cell. Biol."},{"issue":"3","key":"1240_CR49","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1158\/0008-5472.CAN-20-2906","volume":"81","author":"D Strepkos","year":"2021","unstructured":"D. Strepkos, M. Markouli, A. Klonou, A.G. Papavassiliou, C. Piperi, Histone Methyltransferase SETDB1: A Common Denominator of Tumorigenesis with Therapeutic Potential. Cancer Res. 81(3), 525\u2013534 (2021)","journal-title":"Cancer Res."},{"issue":"5","key":"1240_CR50","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/s41419-020-2561-6","volume":"11","author":"N Cao","year":"2020","unstructured":"N. Cao, Y. Yu, H. Zhu, M. Chen, P. Chen, M. Zhuo et al., SETDB1 promotes the progression of colorectal cancer via epigenetically silencing p21 expression. Cell. Death Dis. 11(5), 351 (2020)","journal-title":"Cell. Death Dis."},{"key":"1240_CR51","first-page":"e922982","volume":"26","author":"Z Zhou","year":"2020","unstructured":"Z. Zhou, B. Wu, X. Tang, W. Yang, Q. Zou, H. Wang, High SET Domain Bifurcated 1 (SETDB1) Expression Predicts Poor Prognosis in Breast Carcinoma. Med. Sci. Monit. 26, e922982 (2020)","journal-title":"Med. Sci. Monit."},{"issue":"2","key":"1240_CR52","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/path.5568","volume":"253","author":"W Shang","year":"2021","unstructured":"W. Shang, Y. Wang, X. Liang et al., Setdb1 promotes gastric carcinogenesis and metastasis via upregulation of ccnd1 and mmp9 expression. J. Pathol. 253(2), 148\u2013159 (2021)","journal-title":"J. Pathol."},{"key":"1240_CR53","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1038\/cdd.2017.99","volume":"24","author":"N Furth","year":"2017","unstructured":"N. Furth, Y. Aylon, The LATS1 and LATS2 tumor suppressors: beyond the Hippo pathway. Cell. Death Differ. 24, 1488\u20131501 (2017)","journal-title":"Cell. Death Differ."},{"issue":"1","key":"1240_CR54","doi-asserted-by":"publisher","first-page":"e3000591","DOI":"10.1371\/journal.pbio.3000591","volume":"18","author":"E Stampouloglou","year":"2020","unstructured":"E. Stampouloglou, N. Cheng, A. Federico, E. Slaby, S. Monti, G.L. Szeto et al., Yap suppresses T-cell function and infiltration in the tumor microenvironment. PLoS Biol. 18(1), e3000591 (2020)","journal-title":"PLoS Biol."},{"key":"1240_CR55","doi-asserted-by":"publisher","first-page":"580","DOI":"10.3389\/fimmu.2020.00580","volume":"11","author":"A Lebid","year":"2020","unstructured":"A. Lebid, L. Chung, D.M. Pardoll, F. Pan, YAP Attenuates CD8 T Cell-Mediated Anti-tumor Response. Front. Immunol. 11, 580 (2020)","journal-title":"Front. Immunol."},{"issue":"1","key":"1240_CR56","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13045-017-0421-3","volume":"10","author":"YJ Huang","year":"2017","unstructured":"Y.J. Huang, C.K. Yang, P.L. Wei, T.T. Huynh, J. Whang-Peng, T.C. Meng et al., Ovatodiolide suppresses colon tumorigenesis and prevents polarization of M2 tumor-associated macrophages through YAP oncogenic pathways. J. Hematol. Oncol. 10(1), 60 (2017)","journal-title":"J. Hematol. Oncol."},{"key":"1240_CR57","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/j.1600-065X.2008.00600.x","volume":"222","author":"M Johansson","year":"2008","unstructured":"M. Johansson, D.G. Denardo, L.M. Coussens, Polarized immune responses differentially regulate cancer development. Immunol. Rev. 222, 145\u2013154 (2008)","journal-title":"Immunol. Rev."},{"issue":"7","key":"1240_CR58","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1038\/ni.3748","volume":"18","author":"J Geng","year":"2017","unstructured":"J. Geng, S. Yu, H. Zhao, X. Sun, X. Li, P. Wang et al., The transcriptional coactivator TAZ regulates reciprocal differentiation of TH17 cells and Treg cells. Nat. Immunol. 18(7), 800\u2013812 (2017)","journal-title":"Nat. Immunol."},{"issue":"3","key":"1240_CR59","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1182\/bloodadvances.2018027870","volume":"4","author":"L Huang","year":"2020","unstructured":"L. Huang, X. Sun, D. Yang, X. Dai, P. Jiang, X. Bai et al., WASP and Mst1 coregulate B-cell development and B-cell receptor signaling. Blood Adv. 4(3), 573\u2013585 (2020)","journal-title":"Blood Adv."},{"issue":"1","key":"1240_CR60","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1158\/2159-8290.CD-15-0224","volume":"6","author":"G Wang","year":"2016","unstructured":"G. Wang, X. Lu, P. Dey, P. Deng, C.C. Wu, S. Jiang et al., Targeting YAP-Dependent MDSC Infiltration Impairs Tumor Progression. Cancer Discov. 6(1), 80\u201395 (2016)","journal-title":"Cancer Discov"},{"issue":"7708","key":"1240_CR61","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41586-018-0177-0","volume":"558","author":"X Du","year":"2018","unstructured":"X. Du, J. Wen, Y. Wang, P.W.F. Karmaus, A. Khatamian, H. Tan et al., Hippo\/Mst signalling couples metabolic state and immune function of CD8\u03b1+ dendritic cells. Nature. 558(7708), 141\u2013145 (2018)","journal-title":"Nature"},{"issue":"4","key":"1240_CR62","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3390\/biomedicines6040114","volume":"6","author":"PC Hsu","year":"2018","unstructured":"P.C. Hsu, C.T. Yang, D.M. Jablons, L. You, The Role of Yes-Associated Protein (YAP) in Regulating Programmed Death-Ligand 1 (PD-L1) in Thoracic Cancer. Biomedicines. 6(4), 114 (2018)","journal-title":"Biomedicines"}],"container-title":["Cellular Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13402-026-01240-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-026-01240-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13402-026-01240-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T01:04:05Z","timestamp":1789520645000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13402-026-01240-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":62,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["1240"],"URL":"https:\/\/doi.org\/10.1007\/s13402-026-01240-3","relation":{},"ISSN":["2211-3436"],"issn-type":[{"value":"2211-3436","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]},"assertion":[{"value":"2 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in accordance with the principles of the Declaration of Helsinki principles. It was approved by the Animal Use and Care Committees at the Second Xiangya hospital, Central South University (approval number 20240597).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"117"}}